A method for promoting in vitro refolding and improving immunogenicity of low-molecular-weight proteins
An immunogenic and external renaturation technology, which is applied in the preparation method of peptides, chemical instruments and methods, immunoglobulin, etc., can solve the problem of incorrect protein structure, PEG and its derivatives cannot be renatured with antigen molecules, antibody Problems such as excessive difference in nature
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0048] Using maltose binding protein (MBP) as carrier protein, construct the expression plasmid of renaturation tool molecule according to the requirements of 1.1. The truncation of von Willebrand Factor (vWF) with a molecular weight of 15Kd was used to construct an expression plasmid according to the requirements of 1.2. The ELP sequence used was -VPGAG-VPGAG-. The antigen was obtained for immunizing New Zealand big ear white to prepare polyclonal antibodies. Elisa detection of the immunization process showed that with the increase of the number of immunizations, the antiserum titer of the antigen experimental group containing ELP label was significantly higher than that of the antigen control group without ELP label . Compared with the control group without ELP label, the antiserum titer increased by about 4 times to 1:3000 (e.g. Image 6 shown). The antigen fused with ELP tag achieved better immune effect than conventional renatured antigen.
Embodiment 2
[0050] Using glutathione-S-transferase (GST) as the carrier protein, construct the expression plasmid of the renaturation tool molecule according to the requirements of 1.1. The truncation of Heparin-Binding Protein (HBP) with a molecular weight of 17Kd was used to construct an expression plasmid according to the requirements of 1.2. The ELP sequence used was -VPGSG-VPGSG-VPGSG-. Antigens were obtained and used to immunize BALB / C mice to prepare monoclonal antibodies. Elisa detection of the immunization process showed that with the increase of the number of immunizations, the antiserum titer of the antigen experimental group containing ELP tags was significantly higher than that of the antigens without ELP tags test group. Compared with the control group without ELP label, the antiserum titer increased by 5 times to 1:10000 (e.g. Figure 7 shown). The antigen fused with ELP tag achieved better immune effect than conventional renatured antigen.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


